Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …

Obesity is a multifactorial disease resulting in excessive accumulation of adipose tissue.
Over the last decade, growing evidence has identified the gut microbiota as a potential factor …

Despite milestones in preventive measures and treatment, cardiovascular disease (CVD)
remains associated with a high burden of morbidity and mortality. The protracted nature of …

Emerging data have demonstrated a strong association between the gut microbiota and the
development of cardiovascular disease (CVD) risk factors such as atherosclerosis …

Trimethylamine N-oxide (TMAO) is a biologically active molecule and is a putative promoter
of chronic diseases including atherosclerosis in humans. Host intestinal bacteria produce its …

Objectives: Vascular calcification is highly prevalent in patients with chronic kidney disease.
Increased plasma trimethylamine N-oxide (TMAO), a gut microbiota-dependent product …

In recent years, accumulating evidence has indicated the importance of gut microbiota in
maintaining human health. Gut dysbiosis is associated with the pathogenesis of a number of …

The importance of gut microbiota in health and disease is being highlighted by numerous
research groups worldwide. Atherosclerosis, the leading cause of heart disease and stroke …

Trimethylamine N‐oxide (TMAO) is a biologically active molecule generated by the gut
microbiota. Accumulating evidences have indicated a close association between high …

Circulating trimethylamine N‐oxide (TMAO), a canonical metabolite from gut flora, has been
related to the risk of cardiovascular disorders. However, the association between circulating …